21 CFR Part 882 · Neurological Devices

21 CFR 882.5890

Transcutaneous electrical nerve stimulator for pain relief

21 CFR 882.5890 is the regulation titled “Transcutaneous electrical nerve stimulator for pain relief” in 21 CFR Part 882, Neurological Devices. Since 2021, 2 FDA warning letters have cited it.

Letters citing it
2 since 2021
Jan 1 to Oct 30, 2026
1 against 0 on the same dates in 2025
Most often cited with
21 CFR 807.81, in 2 letters
Closed out
0% of these letters have a published close-out
See the 2 letters citing 21 CFR 882.5890 →

Letters citing it, by year issued

All are medical device letters. 2026 runs to Oct 30, 2026. Pick a year to see its letters.

  1. 02021
  2. 02022
  3. 12023
  4. 02024
  5. 02025
  6. 12026

The regulation

Read the text of 21 CFR 882.5890 (eCFR, as of Sep 1, 2026)

(a) Identification. A transcutaneous electrical nerve stimulator for pain relief is a device used to apply an electrical current to electrodes on a patient's skin to treat pain.

(b) Classification. Class II (performance standards).

Text from eCFR as of Sep 1, 2026.

Cited alongside it

Regulations that appear in the same letters as 21 CFR 882.5890.

Latest letters citing it

The 2 letters citing 21 CFR 882.5890 that FDA posted most recently.

See the 2 letters citing 21 CFR 882.5890 →
For regulated teams

Put this kind of reading to
work on your own records.

Botable builds and runs a custom AI layer around the software you already use, so your team can do the job you hired them for.

Counts include every citation in a letter, as the Letters filter does. How this database is built.

Every letter by dateHow this database is built

FDA Warning Letter Alerts

Share this view

Send the same filters, search and view to a colleague.

You choose what to post or send. Sharing a link does not change access to this site.